Skip to main content

Table 8 Relation between type of authorization and effectiveness

From: Oncologic orphan drugs approved in the EU – do clinical trial data correspond with real-world effectiveness?

 

Effectiveness

 

Survival benefit > 3 months

Survival benefit < 3 months, unknown magnitude or no benefit

Total

Authorization

Full

3

1

4

Conditional or exceptional

3

3

6

 

Total

6

4

10